Overview

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Long term safety and efficacy (12 months) of levodopa-carbidopa intestinal gel.
Phase:
Phase 3
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Collaborator:
Quintiles, Inc.
Treatments:
Carbidopa
Carbidopa, levodopa drug combination
Levodopa